- Investing Ideas
- Australian Pharmaceuticals & Biotech Profitable Climbers
Australian Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
Clinuvel Pharmaceuticals
Market Cap: AU$532.1m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.60
7D
-4.2%
1Y
-7.0%
Medical Developments International
Market Cap: AU$51.3m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.46
7D
1.1%
1Y
-50.0%
Telix Pharmaceuticals
Market Cap: AU$3.0b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$8.76
7D
-11.1%
1Y
-67.7%